Company intelligence / Profile preview

Bellen Chemistry

Beijing, Beijing, Chinabellenchem.com ↗
Ownership
Private
Employees
~1000
Development stage
Other
01

Overview

Bellen Chemistry provides integrated chemistry CRO/CDMO services for small molecule compound synthesis, spanning discovery to commercial stages, including recent offerings in PROTAC chemistry; it does not directly develop its own therapeutics.

Modalities
Small moleculeProteolysis-targeting chimera therapy
Industry
Drug Discovery Services

Beyond the preview

Go deeper on Bellen Chemistry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bellen Chemistry.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call